Asker Healthcare Group AB
F:I88
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Asker Healthcare Group AB
F:I88
|
SE |
|
C
|
China Oriental Group Co Ltd
F:ORG
|
HK |
|
E
|
Enlivex Therapeutics Ltd
F:1BT
|
IL |
|
A
|
Axonics Inc
SWB:0I3
|
US |
|
Parkway Corporate Ltd
F:4IP
|
AU |
Wall St Price Targets
I88 Price Targets Summary
Asker Healthcare Group AB
According to Wall Street analysts, the average 1-year price target for I88 is 10.13 EUR with a low forecast of 8.45 EUR and a high forecast of 11.25 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is I88's stock price target?
Price Target
10.13
EUR
According to Wall Street analysts, the average 1-year price target for I88 is 10.13 EUR with a low forecast of 8.45 EUR and a high forecast of 11.25 EUR.
What is the Revenue forecast for Asker Healthcare Group AB?
Projected CAGR
-6%
Over the last 2 years, the compound annual growth rate for Revenue has been 12%. The projected CAGR for the next 5 years is -6%.
What is the Gross Profit forecast for Asker Healthcare Group AB?
Projected CAGR
9%
Over the last 2 years, the compound annual growth rate for Gross Profit has been 23%. The projected CAGR for the next 5 years is 9%.
What is the Operating Income forecast for Asker Healthcare Group AB?
Projected CAGR
5%
Over the last 2 years, the compound annual growth rate for Operating Income has been 31%. The projected CAGR for the next 4 years is 5%.
What is the Pre-Tax Income forecast for Asker Healthcare Group AB?
Projected CAGR
12%
Over the last 2 years, the compound annual growth rate for Pre-Tax Income has been 46%. The projected CAGR for the next 3 years is 12%.
What is the Net Income forecast for Asker Healthcare Group AB?
Projected CAGR
22%
Over the last 2 years, the compound annual growth rate for Net Income has been 51%. The projected CAGR for the next 4 years is 22%.
